10-week, but not 7-week, Dapagliflozin Treatment Improves Severe Renal Impairment in the Uni-nephrectomized SDT fatty rat, a 10-week Model of Advanced Renal Complications and Glomerular Filtration Rate Decline.

Key Word:
Dapagliflozin、Renal Impairment、Uni-nephrectomized、Renal Complications、Glomerular Filtration Rate、hypertensive, obese, type 2 diabetic model

François Briand¹, Masami Shinohara², Emmanuel Brousseau¹, Takeshi Ohta³, Yasushi Kageyama², Thierry Sulpice¹

¹Physiogenex, Labège, France; ²CLEA Japan Inc. Meguro-ku, Tokyo, Japan, ³Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan

For more details, please click here (Google Search)

• ISN-WCN 2017: Centro Banamex in, Mexico City, Mexico.
• April 21-25, 2017

Related CLEA Japan product: SDT fatty/Jcl

For the animal model, please click here ▼

 https://www.clea-japan.com/en/products/diabetes/item_a0150

 

Inquiry

If you have any questions, please feel free to contact us.